SUSQUEHANNA INTERNATIONAL GROUP, LLP - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 134 filers reported holding KURA ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$1,631,239
-34.4%
178,864
-23.9%
0.00%
Q2 2023$2,487,136
+67.0%
235,079
+93.1%
0.00%
Q1 2023$1,488,941
-4.0%
121,745
-2.6%
0.00%
Q4 2022$1,551,647
-55.9%
125,032
-51.4%
0.00%
Q3 2022$3,515,000
+170.8%
257,370
+263.5%
0.00%
Q2 2022$1,298,000
-42.3%
70,800
-49.4%
0.00%
Q1 2022$2,250,000
-82.1%
139,929
-84.4%
0.00%
Q4 2021$12,540,000
+631.2%
895,722
+878.1%
0.00%
Q3 2021$1,715,000
-52.1%
91,575
-46.6%
0.00%
Q2 2021$3,578,000
-55.5%
171,600
-39.7%
0.00%
-100.0%
Q1 2021$8,046,000
-65.0%
284,595
-59.6%
0.00%
-66.7%
Q4 2020$22,984,000
+122.7%
703,706
+109.0%
0.00%
+50.0%
Q3 2020$10,319,000
+459.0%
336,744
+197.3%
0.00%
Q2 2020$1,846,000
+742.9%
113,258
+414.5%
0.00%
Q1 2020$219,000
+23.7%
22,014
+70.7%
0.00%
Q4 2019$177,000
-37.7%
12,900
-31.0%
0.00%
Q3 2019$284,000
-80.3%
18,697
-74.5%
0.00%
Q2 2019$1,443,000
+164.3%
73,282
+122.7%
0.00%
Q1 2019$546,000
+31.9%
32,900
+39.4%
0.00%
Q3 2018$414,000
-82.1%
23,600
-81.5%
0.00%
-100.0%
Q2 2018$2,319,000
+1755.2%
127,400
+800.0%
0.00%
Q1 2017$125,00014,1560.00%
Other shareholders
KURA ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders